A web tool for designing and conducting phase I trials using the continual reassessment method

por Wages, Nolan A., Petroni, Gina R.
Publicado 2018

Impact of dose feasibility on the conduct of phase I trials of adoptive cell therapy

por Bagley, Evan M., Wages, Nolan A.
Publicado 2021

Design considerations for early-phase clinical trials of immune-oncology agents

por Wages, Nolan A., Chiuzan, Cody, Panageas, Katherine S.
Publicado 2018

Application of the patient-reported outcomes continual reassessment method to a phase I study of radiotherapy in endometrial cancer

por Wages, Nolan A., Nelson, Bailey, Kharofa, Jordan, Meier, Teresa
Publicado 2022

Concurrent dose-finding of a novel cancer drug with and without a second agent

por Wages, Nolan A., Saleh, Ramy R., Braun, Thomas M.
Publicado 2023

Local continual reassessment methods for dose finding and optimization in drug-combination trials

por Zhang, Jingyi, Yan, Fangrong, Wages, Nolan A, Lin, Ruitao
Publicado 2023

Bayesian Design for Identifying Cohort-Specific Optimal Dose Combinations Based on Multiple Endpoints: Application to a Phase I Trial in Non-Small Cell Lung Cancer

por Horton, Bethany Jablonski, Wages, Nolan A., Gentzler, Ryan D.
Publicado 2021

Defining the effects of age and gender on clinical immune response to cancer vaccination

por Ramirez, Adriana, Wages, Nolan, Smolkin, Mark E, Slingluff, Craig L
Publicado 2014

Obtaining the Optimal Dose in Alcohol Dependence Studies

por Wages, Nolan A., Liu, Lei, O’Quigley, John, Johnson, Bankole A.
Publicado 2012

Relationship of dose to vascular target volumes and local failure in pancreatic cancer patients undergoing neoadjuvant chemoradiation

por Nelson, Bailey, Barrord, Michelle, Wang, Kyle, Wages, Nolan A., Sudhoff, Mickaela, Kharofa, Jordan
Publicado 2022

Efficient dose-finding for drug combination studies involving a shift in study populations

por Wages, Nolan A., Millard, Trish A., Dillon, Patrick M., Brenin, Christiana M., Petroni, Gina R.
Publicado 2020

Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma

por Lynch, Kevin T, Young, Samuel J, Meneveau, Max O, Wages, Nolan A, Engelhard, Victor H, Slingluff Jr, Craig L, Mauldin, Ileana S
Publicado 2021

Dose-finding study of ibrutinib and venetoclax in relapsed or refractory mantle cell lymphoma

por Portell, Craig A., Wages, Nolan A., Kahl, Brad S., Budde, Lihua E., Chen, Robert W., Cohen, Jonathon B., Varhegyi, Nikole E., Petroni, Gina R., Williams, Michael E.
Publicado 2022

Proliferating CD8(+) T Cell Infiltrates Are Associated with Improved Survival in Glioblastoma

por Mauldin, Ileana S., Jo, Jasmin, Wages, Nolan A., Yogendran, Lalanthica V., Mahmutovic, Adela, Young, Samuel J., Lopes, Maria Beatriz, Slingluff, Craig L., Erickson, Loren D., Fadul, Camilo E.
Publicado 2021

Venetoclax with decitabine or azacitidine in the first‐line treatment of acute myeloid leukemia

por Bouligny, Ian M., Murray, Graeme, Doyel, Michael, Patel, Tilak, Boron, Josh, Tran, Valerie, Gor, Juhi, Hang, Yiwei, Alnimer, Yanal, Zacholski, Kyle, Venn, Chad, Wages, Nolan A., Grant, Steven, Maher, Keri R.
Publicado 2023

Venetoclax with Decitabine or Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia

por Bouligny, Ian M., Murray, Graeme, Ho, Thuy, Doyel, Michael, Patel, Tilak, Boron, Josh, Tran, Valerie, Gor, Juhi, Hang, Yiwei, Alnimer, Yanal, Zacholski, Kyle, Venn, Chad, Wages, Nolan A., Grant, Steven, Maher, Keri R.
Publicado 2023

A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patients

por Melssen, Marit M., Petroni, Gina R., Chianese-Bullock, Kimberly A., Wages, Nolan A., Grosh, William W., Varhegyi, Nikole, Smolkin, Mark E., Smith, Kelly T., Galeassi, Nadejda V., Deacon, Donna H., Gaughan, Elizabeth M., Slingluff, Craig L.
Publicado 2019

Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund’s adjuvant (IFA) for resected high-risk melanoma

por Patel, Sapna P, Petroni, Gina R, Roszik, Jason, Olson, Walter C, Wages, Nolan A, Chianese-Bullock, Kimberly A, Smolkin, Mark, Varhegyi, Nikole, Gaughan, Elizabeth, Smith, Kelly T, Haden, Kathleen, Hall, Emily H, Gnjatic, Sacha, Hwu, Patrick, Slingluff, Craig L
Publicado 2021

Pilot clinical trials testing the safety and effects on the metastatic melanoma microenvironment of intratumoral interferon-gamma or imiquimod, plus a multipeptide melanoma vaccine

por Mauldin, Ileana S, Wages, Nolan A, Stowman, Anne M, Wang, Ena, Smolkin, Mark E, Olson, Walter C, Deacon, Donna H, Smith, Kelly T, Galeassi, Nadejda, Teague, Jessica E, Clark, Rachael A, Marincola, Francesco M, Petroni, Gina R, Mullins, David W, Slingluff, Craig L
Publicado 2015

MYBL2-Driven Transcriptional Programs Link Replication Stress and Error-prone DNA Repair With Genomic Instability in Lung Adenocarcinoma

por Morris, Benjamin B., Wages, Nolan A., Grant, Patrick A., Stukenberg, P. Todd, Gentzler, Ryan D., Hall, Richard D., Akerley, Wallace L., Varghese, Thomas K., Arnold, Susanne M., Williams, Terence M., Coppola, Vincenzo, Jones, David R., Auble, David T., Mayo, Marty W.
Publicado 2021